An efficient stereoselective synthesis of the orally active NK
1 receptor antagonist Aprepitant isdescribed. A direct condensation of
N-benzyl ethanolamine with glyoxylic acid yielded a 2-hydroxy-1,4-oxazin-3-one which was activated as the corresponding trifluoroacetate. A Lewis acid mediated couplingwith enantiopure (
R)-1-(3,5-bis(trifluoromethyl)phenyl)ethan-1-ol afforded a 1:1 mixture of acetal diastereomers which was converted into a single isomer via a novel crystallization-induced asymmetric transformation. The resulting 1,4-oxazin-3-one was converted via a unique and highly stereoselective one-potprocess to the desired
-(fluorophenyl)morpholine derivative. Interesting and unexpected [1,2]-Wittig and[1,3]-sigmatropic rearrangements were identified during the optimization of these key steps. In the finalstep, a triazolinone side chain was appended to the morpholine core. The targeted clinical candidate wasthus obtained in 55% overall yield over the longest linear sequence.